表紙
市場調查報告書

解剖病理學市場:各產品、各類型、各技術、各用途、各終端用戶、各地區趨勢 - 全球產業分析與預測

Anatomic Pathology Market Research Report: By Product, type, technique, Application, End-User, Regional Insight - Global Industry Analysis and Forecast to 2024

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 888886
出版日期 內容資訊 英文 227 Pages
商品交期: 2-3個工作天內
價格
解剖病理學市場:各產品、各類型、各技術、各用途、各終端用戶、各地區趨勢 - 全球產業分析與預測 Anatomic Pathology Market Research Report: By Product, type, technique, Application, End-User, Regional Insight - Global Industry Analysis and Forecast to 2024
出版日期: 2019年05月01日內容資訊: 英文 227 Pages
簡介

本報告提供全球解剖病理學市場調查分析,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊彙整。

第1章 調查的過程

第2章 調查方法

第3章 摘要整理

第4章 簡介

  • 市場區隔定義
    • 各產品
    • 各實驗類型
    • 各技術
    • 各用途
    • 各終端用戶
  • 市場趨勢
    • 趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 波特五力分析
  • 技術進步
  • 相關法規
  • 價格分析

第5章 全球市場規模與預測

  • 各產品
  • 各實驗類型
  • 各技術
  • 各用途
  • 各終端用戶
  • 各地區

第6章 北美市場

第7章 歐洲市場

第8章 亞太地區市場

第9章 南美市場

第10章 中東、非洲市場

第11章 競爭趨勢

第12章 企業簡介

第13章 附錄

目錄

Title:
Anatomic Pathology Market Research Report: By Product (Consumables, Instruments), type (Histopathology, Cytopathology, Surgical Pathology), technique (Special Staining, Immunohistochemistry, Electron Microscopy, Genetic Testing), Application (Disease Diagnosis, Drug Discovery), End-User (Hospitals and Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Academic and Research Organizations), Regional Insight (U.S., Canada, France, Germany, Italy, Spain, U.K., Russia, Sweden, Norway, Belgium, Switzerland, Poland, Austria, Japan, China, Thailand, Indonesia, Singapore, Australia, Malaysia, South Korea, India, Mexico, Brazil, Argentina, Chile, Saudi Arabia, U.A.E., Israel, South Africa) - Global Industry Analysis and Forecast to 2024.

The global anatomic pathology market is projected to attain a size of $24.3 billion by 2024, progressing at a 5.8% CAGR during the forecast period. The increasing prevalence of chronic diseases, developments in technology, and surging geriatric population are some of the major reasons behind the growth of the market. On the basis of application, the market is categorized into drug discovery, disease diagnosis, and others. Out of these, the disease diagnosis category is expected to hold the largest share of more than 65.0% in the market by 2024.

This is attributed to the surging aging population and rising number of patients suffering from the chronic ailments. When segmented by end user, the anatomic pathology market is classified into diagnostic laboratories, ambulatory surgical centers, hospitals and clinics, and academic and research organizations. Among these, in 2018, diagnostic laboratories led the market with a share of 45.8%, followed by hospitals and clinics that held a 31.4% share. The reason behind this is that these laboratories are less expensive as compared to hospitals and clinics.

The Asia-Pacific (APAC) anatomic pathology market is predicted to witness the fastest growth at a 6.7% CAGR during the forecast period. The key factors responsible for such rapid progress would be the acceptance of personalized medicine, growing number of chronic ailment patients, increasing investment in diagnostic research by non-government and government organizations, and entry of established players in the region. The increasing entrance rate of international players in the market is helping in better availability of advanced and innovative anatomic pathology consumables and instruments in APAC.

For instance, in January 2019, Nichirei Bioscience (one of the leading suppliers of diagnostic and biological products in Japan) collaborated with Biocartis Group NV for the product registration and exclusive distribution of molecular diagnostic (MDx) oncology tests, developed by Biocartis, in Japan, which work on the sample-to-result Idylla platform, which is fully automated, Under this, Nichirei Bioscience agreed to get the regulatory approval of the Japanese Ministry of Health, Labour, and Welfare for Idylla MDx oncology tests. After the registration, Nichirei Bioscience aims to provide Biocartis' Idylla platform to 2,000 pathology laboratories within its commercial network in Japan.

The key players operating in the anatomic pathology market are gearing up to introduce innovative solutions to improve their market presence. For instance, in February 2019, Quest Diagnostics Inc., a U.S.-based diagnostic information services provider, purchased the clinical laboratory services unit of Boyce & Bynum Pathology Laboratories (BBPL), a leading supplier of diagnostic and clinical laboratory services in the Midwest. The acquisition is aimed at offering a larger portfolio of anatomic pathology and innovative clinical laboratory services to providers and patients throughout the region.

Table of Content

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Product
    • 1.3.2 Market Segmentation by Test Type
    • 1.3.3 Market Segmentation by Technique
    • 1.3.4 Market Segmentation by Application
    • 1.3.5 Market Segmentation by End User
    • 1.3.6 Market Segmentation by Region
    • 1.3.7 Analysis Period
    • 1.3.8 Market Data Reporting Unit
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Product
      • 4.1.1.1 Consumables
        • 4.1.1.1.1 Reagents
        • 4.1.1.1.1.1 Fixatives
        • 4.1.1.1.1.2 Stains and dyes
        • 4.1.1.1.1.3 Others
        • 4.1.1.1.2 Antibodies
        • 4.1.1.1.3 Kits
        • 4.1.1.1.4 Probes
        • 4.1.1.1.5 Others
      • 4.1.1.2 Instruments
        • 4.1.1.2.1 Tissue processors
        • 4.1.1.2.2 Slide stainers
        • 4.1.1.2.3 Microtomes
        • 4.1.1.2.4 Centrifuges
        • 4.1.1.2.5 Cryostats
        • 4.1.1.2.6 Others
    • 4.1.2 By Test Type
      • 4.1.2.1 Histopathology
      • 4.1.2.2 Cytopathology
      • 4.1.2.3 Surgical pathology
    • 4.1.3 By Technique
      • 4.1.3.1 Special staining
      • 4.1.3.2 Immunohistochemistry
      • 4.1.3.3 Electron microscopy
      • 4.1.3.4 Genetic testing
      • 4.1.3.5 Others
    • 4.1.4 By Application
      • 4.1.4.1 Disease diagnosis
        • 4.1.4.1.1 Cardiology
        • 4.1.4.1.2 Oncology
        • 4.1.4.1.3 Hepatology
        • 4.1.4.1.4 Nephrology
        • 4.1.4.1.5 Others
      • 4.1.4.2 Drug discovery
      • 4.1.4.3 Others
    • 4.1.5 By End User
      • 4.1.5.1 Diagnostic laboratories
      • 4.1.5.2 Hospitals and clinics
      • 4.1.5.3 Ambulatory surgical centers
      • 4.1.5.4 Academic and research organizations
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Adoption of new technologies
      • 4.2.1.2 Increasing number of collaborations and acquisitions
    • 4.2.2 Drivers
      • 4.2.2.1 Increasing incidence of chronic diseases
      • 4.2.2.2 Rising geriatric population
      • 4.2.2.3 Advancements in technologies
    • 4.2.3 Restraints
      • 4.2.3.1 Increasing market consolidation
      • 4.2.3.2 Lack of monetary support from healthcare insurance providers
      • 4.2.3.3 Inability of underdeveloped countries to adopt digital anatomic pathology
    • 4.2.4 Opportunity
      • 4.2.4.1 Increasing medical tourism in APAC
      • 4.2.4.2 Emerging economies across the world
  • 4.3 Porter's Five Forces Analysis
  • 4.4 Technological Advancements
    • 4.4.1 WSI
    • 4.4.2 LOC
  • 4.5 Regulatory Framework
    • 4.5.1 North America
    • 4.5.2 Europe
    • 4.5.3 APAC
    • 4.5.4 LATAM
    • 4.5.5 MEA
  • 4.6 Pricing Analysis

Chapter 5. Global Market Size and Forecast

  • 5.1 By Product
    • 5.1.1 Consumables Market by Type
      • 5.1.1.1 Reagents market by type
    • 5.1.2 Instruments Market by Type
  • 5.2 By Test Type
  • 5.3 By Technique
  • 5.4 By Application
    • 5.4.1 Disease Diagnosis Market by Type
  • 5.5 By End User
  • 5.6 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Product
    • 6.1.1 Consumables Market by Type
      • 6.1.1.1 Reagents market by type
    • 6.1.2 Instruments Market by Type
  • 6.2 By Test Type
  • 6.3 By Technique
  • 6.4 By Application
    • 6.4.1 Disease Diagnosis Market by Type
  • 6.5 By End User
  • 6.6 By Country

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Product
    • 7.1.1 Consumables Market by Type
      • 7.1.1.1 Reagents market by type
    • 7.1.2 Instruments Market by Type
  • 7.2 By Test Type
  • 7.3 By Technique
  • 7.4 By Application
    • 7.4.1 Disease Diagnosis Market by Type
  • 7.5 By End User
  • 7.6 By Country

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Product
    • 8.1.1 Consumables Market by Type
      • 8.1.1.1 Reagents market by type
    • 8.1.2 Instruments Market by Type
  • 8.2 By Test Type
  • 8.3 By Technique
  • 8.4 By Application
    • 8.4.1 Disease Diagnosis Market by Type
  • 8.5 By End User
  • 8.6 By Country

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Product
    • 9.1.1 Consumables Market by Type
      • 9.1.1.1 Reagents market by type
    • 9.1.2 Instruments Market by Type
  • 9.2 By Test Type
  • 9.3 By Technique
  • 9.4 By Application
    • 9.4.1 Disease Diagnosis by Type
  • 9.5 By End User
  • 9.6 By Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Product
    • 10.1.1 Consumables by Type
      • 10.1.1.1 Reagents market by type
    • 10.1.2 Instruments Market by Type
  • 10.2 By Test Type
  • 10.3 By Technique
  • 10.4 By Application
    • 10.4.1 Disease Diagnosis Market by Type
  • 10.5 By End User
  • 10.6 By Country

Chapter 11. Competitive Landscape

  • 11.1 Company Benchmarking Based on Offerings
  • 11.2 Technique Benchmarking of Key Players
  • 11.3 Global Strategic Developments of Key Players
    • 11.3.1 Acquisitions and Collaborations
    • 11.3.2 New Product Launches and Patent Approvals

Chapter 12. Company Profiles

  • 12.1 Key Players
    • 12.1.1 Thermo Fisher Scientific Inc.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Product and service offerings
      • 12.1.1.3 Key financial summary
    • 12.1.2 Danaher Corporation
      • 12.1.2.1 Business overview
      • 12.1.2.2 Product and service offerings
      • 12.1.2.3 Key financial summary
    • 12.1.3 F. Hoffmann-La Roche Ltd.
      • 12.1.3.1 Business overview
      • 12.1.3.2 Product and service offerings
      • 12.1.3.3 Key financial summary
    • 12.1.4 Quest Diagnostics Incorporated
      • 12.1.4.1 Business overview
      • 12.1.4.2 Product and service offerings
      • 12.1.4.3 Key financial summary
    • 12.1.5 Bio-Rad Laboratories Inc.
      • 12.1.5.1 Business overview
      • 12.1.5.2 Product and service offerings
      • 12.1.5.3 Key financial summary
    • 12.1.6 Agilent Technologies Inc.
      • 12.1.6.1 Business overview
      • 12.1.6.2 Product and service offerings
      • 12.1.6.3 Key financial summary
    • 12.1.7 Neogenomics Laboratories Inc.
      • 12.1.7.1 Business overview
      • 12.1.7.2 Product and service offerings
      • 12.1.7.3 Key Financial Summary
    • 12.1.8 Abbott Laboratories
      • 12.1.8.1 Business overview
      • 12.1.8.2 Product and service offerings
      • 12.1.8.3 Key financial summary
    • 12.1.9 Sakura Finetek USA Inc.
      • 12.1.9.1 Business overview
      • 12.1.9.2 Product and service offerings
    • 12.1.10 OriGene Technologies Inc.
      • 12.1.10.1 Business overview
      • 12.1.10.2 Product and service offerings
    • 12.1.11 Biocare Medical LLC
      • 12.1.11.1 Business overview
      • 12.1.11.2 Product and service offerings
    • 12.1.12 Sonic Healthcare Limited
      • 12.1.12.1 Business overview
      • 12.1.12.2 Product and service offerings
      • 12.1.12.3 Key financial summary
    • 12.1.13 DTM Print GmBH
      • 12.1.13.1 Business overview
      • 12.1.13.2 Product and service offerings
  • 12.2 Other Players
    • 12.2.1 Caris Life Sciences Inc.
    • 12.2.2 Sunquest Information Systems Inc.
    • 12.2.3 Inform Diagnostics Inc.
    • 12.2.4 Interpath Laboratory Inc.

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports

List of Tables

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 GLOBAL ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2018)
  • TABLE 5 GLOBAL ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019-2024)
  • TABLE 6 GLOBAL ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2014-2018)
  • TABLE 7 GLOBAL ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019-2024)
  • TABLE 8 GLOBAL ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 9 GLOBAL ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 10 GLOBAL ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 11 GLOBAL ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 12 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2018)
  • TABLE 13 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019-2024)
  • TABLE 14 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2018)
  • TABLE 15 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019-2024)
  • TABLE 16 GLOBAL ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2018)
  • TABLE 17 GLOBAL ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019-2024)
  • TABLE 18 GLOBAL ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014- 2018)
  • TABLE 19 GLOBAL ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019- 2024)
  • TABLE 20 GLOBAL ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2018)
  • TABLE 21 GLOBAL ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019-2024)
  • TABLE 22 GLOBAL ANATOMIC PATHOLOGY MARKET, BY REGION, $M (2014-2018)
  • TABLE 23 GLOBAL ANATOMIC PATHOLOGY MARKET, BY REGION, $M (2019-2024)
  • TABLE 24 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2018)
  • TABLE 25 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019-2024)
  • TABLE 26 NORTH AMERICA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2014- 2018)
  • TABLE 27 NORTH AMERICA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019- 2024)
  • TABLE 28 NORTH AMERICA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014- 2018)
  • TABLE 29 NORTH AMERICA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019- 2024)
  • TABLE 30 NORTH AMERICA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014- 2018)
  • TABLE 31 NORTH AMERICA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019- 2024)
  • TABLE 32 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2018)
  • TABLE 33 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019-2024)
  • TABLE 34 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2018)
  • TABLE 35 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019-2024)
  • TABLE 36 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2018)
  • TABLE 37 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019-2024)
  • TABLE 38 NORTH AMERICA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014-2018)
  • TABLE 39 NORTH AMERICA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019-2024)
  • TABLE 40 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2018)
  • TABLE 41 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019-2024)
  • TABLE 42 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014-2014)
  • TABLE 43 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019-2024)
  • TABLE 44 EUROPE ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2018)
  • TABLE 45 EUROPE ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019-2024)
  • TABLE 46 EUROPE ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2014-2018)
  • TABLE 47 EUROPE ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019-2024)
  • TABLE 48 EUROPE ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 49 EUROPE ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 50 EUROPE ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 51 EUROPE ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 52 EUROPE ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2018)
  • TABLE 53 EUROPE ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019-2024)
  • TABLE 54 EUROPE ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2018)
  • TABLE 55 EUROPE ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019-2024)
  • TABLE 56 EUROPE ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2018)
  • TABLE 57 EUROPE ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019-2024)
  • TABLE 58 EUROPE ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014- 2018)
  • TABLE 59 EUROPE ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019- 2024)
  • TABLE 60 EUROPE ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2018)
  • TABLE 61 EUROPE ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019-2024)
  • TABLE 62 EUROPE ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014-2018)
  • TABLE 63 EUROPE ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019-2024)
  • TABLE 64 APAC ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2018)
  • TABLE 65 APAC ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019-2024)
  • TABLE 66 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 67 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 68 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 69 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 70 APAC ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 71 APAC ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 72 APAC ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2018)
  • TABLE 73 APAC ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019-2024)
  • TABLE 74 APAC ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2018)
  • TABLE 75 APAC ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019-2024)
  • TABLE 76 APAC ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2018)
  • TABLE 77 APAC ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019-2024)
  • TABLE 78 APAC ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014- 2018)
  • TABLE 79 APAC ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019- 2024)
  • TABLE 80 APAC ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2018)
  • TABLE 81 APAC ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019-2024)
  • TABLE 82 APAC ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014-2018)
  • TABLE 83 APAC ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019-2024)
  • TABLE 84 LATAM ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2018)
  • TABLE 85 LATAM ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019-2024)
  • TABLE 86 LATAM ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2014-2018)
  • TABLE 87 LATAM ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019-2024)
  • TABLE 88 LATAM ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 89 LATAM ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 90 LATAM ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 91 LATAM ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 92 LATAM ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2018)
  • TABLE 93 LATAM ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019-2024)
  • TABLE 94 LATAM ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2018)
  • TABLE 95 LATAM ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019-2024)
  • TABLE 96 LATAM ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2018)
  • TABLE 97 LATAM ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019-2024)
  • TABLE 98 LATAM ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014- 2018)
  • TABLE 99 LATAM ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019- 2024)
  • TABLE 100 LATAM ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2018)
  • TABLE 101 LATAM ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019-2024)
  • TABLE 102 LATAM ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014-2018)
  • TABLE 103 LATAM ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019-2024)
  • TABLE 104 MEA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2018)
  • TABLE 105 MEA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019-2024)
  • TABLE 106 MEA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2014-2018)
  • TABLE 107 MEA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019-2024)
  • TABLE 108 MEA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 109 MEA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 110 MEA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2018)
  • TABLE 111 MEA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019-2024)
  • TABLE 112 MEA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2018)
  • TABLE 113 MEA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019-2024)
  • TABLE 114 MEA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2018)
  • TABLE 115 MEA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019-2024)
  • TABLE 116 MEA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2018)
  • TABLE 117 MEA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019-2024)
  • TABLE 118 MEA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014- 2018)
  • TABLE 119 MEA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019- 2024)
  • TABLE 120 MEA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2018)
  • TABLE 121 MEA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019-2024)
  • TABLE 122 MEA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014-2018)
  • TABLE 123 MEA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019-2024)
  • TABLE 124 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 125 THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 126 DANAHER CORPORATION - AT A GLANCE
  • TABLE 127 DANAHER CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 128 F. HOFFMANN-LA ROCHE LTD. - AT A GLANCE
  • TABLE 129 F. HOFFMANN-LA ROCHE LTD. - KEY FINANCIAL SUMMARY
  • TABLE 130 QUEST DIAGNOSTICS INCORPORATED - AT A GLANCE
  • TABLE 131 QUEST DIAGNOSTICS INCORPORATED - KEY FINANCIAL SUMMARY
  • TABLE 132 BIO-RAD LABORATORIES INC. - AT A GLANCE
  • TABLE 133 BIO-RAD LABORATORIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 134 AGILENT TECHNOLOGIES INC. - AT A GLANCE
  • TABLE 135 AGILENT TECHNOLOGIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 136 NEOGENOMICS LABORATORIES INC. - AT A GLANCE
  • TABLE 137 NEOGENOMICS LABORATORIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 138 ABBOTT LABORATORIES - AT A GLANCE
  • TABLE 139 ABBOTT LABORATORIES - KEY FINANCIAL SUMMARY
  • TABLE 140 SAKURA FINETEK USA INC. - AT A GLANCE
  • TABLE 141 ORIGENE TECHNOLOGIES INC. - AT A GLANCE
  • TABLE 142 BIOCARE MEDICAL LLC - AT A GLANCE
  • TABLE 143 SONIC HEALTHCARE LIMITED - AT A GLANCE
  • TABLE 144 SONIC HEALTHCARE LIMITED - KEY FINANCIAL SUMMARY
  • TABLE 145 DTM PRINT GMBH - AT A GLANCE
  • TABLE 146 CARIS LIFE SCIENES INC. - AT A GLANCE
  • TABLE 147 SUNQUEST INFORMATION SYSTEMS INC. - AT A GLANCE
  • TABLE 148 INFORM DIAGNOSTICS INC. - AT A GLANCE
  • TABLE 149 INTERPATH LABORATORY INC. - AT A GLANCE

List of Figures

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL ANATOMIC PATHOLOGY MARKET SUMMARY
  • FIG 9 BARGAINING POWER OF BUYERS
  • FIG 10 BARGAINING POWER OF SUPPLIERS
  • FIG 11 INTENSITY OF RIVALRY
  • FIG 12 THREAT OF NEW ENTRANTS
  • FIG 13 THREAT OF SUBSTITUTES
  • FIG 14 GLOBAL ANATOMIC PATHOLOGY MARKET SNAPSHOT
  • FIG 15 GLOBAL ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2024)
  • FIG 16 GLOBAL ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2014-2024)
  • FIG 17 GLOBAL ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 18 GLOBAL ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 19 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2024)
  • FIG 20 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2024)
  • FIG 21 GLOBAL ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2024)
  • FIG 22 GLOBAL ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2024)
  • FIG 23 WORLDWIDE MAJOR MARKETS FOR ANATOMIC PATHOLOGY
  • FIG 24 NORTH AMERICA ANATOMIC PATHOLOGY MARKET SNAPSHOT
  • FIG 25 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2024)
  • FIG 26 NORTH AMERICA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2014-2024)
  • FIG 27 NORTH AMERICA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 28 NORTH AMERICA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 29 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2024)
  • FIG 30 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2024)
  • FIG 31 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2024)
  • FIG 32 NORTH AMERICA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014-2024)
  • FIG 33 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2024)
  • FIG 34 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014-2024)
  • FIG 35 EUROPE ANATOMIC PATHOLOGY MARKET SNAPSHOT
  • FIG 36 EUROPE ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2024)
  • FIG 37 EUROPE ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2014-2024)
  • FIG 38 EUROPE ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 39 EUROPE ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 40 EUROPE ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2024)
  • FIG 41 EUROPE ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2024)
  • FIG 42 EUROPE ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2024)
  • FIG 43 EUROPE ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014-2024)
  • FIG 44 EUROPE ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2024)
  • FIG 45 EUROPE ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014-2024)
  • FIG 46 APAC ANATOMIC PATHOLOGY MARKET SNAPSHOT
  • FIG 47 APAC ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2024)
  • FIG 48 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 49 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 50 APAC ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 51 APAC ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2024)
  • FIG 52 APAC ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2024)
  • FIG 53 APAC ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2024)
  • FIG 54 APAC ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014-2024)
  • FIG 55 APAC ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2024)
  • FIG 56 APAC ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014-2024)
  • FIG 57 LATAM ANATOMIC PATHOLOGY MARKET SNAPSHOT
  • FIG 58 LATAM ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2024)
  • FIG 59 LATAM ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2014-2024)
  • FIG 60 LATAM ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 61 LATAM ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 62 LATAM ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2024)
  • FIG 63 LATAM ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2024)
  • FIG 64 LATAM ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2024)
  • FIG 65 LATAM ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014-2024)
  • FIG 66 LATAM ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2024)
  • FIG 67 LATAM ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014-2024)
  • FIG 68 MEA ANATOMIC PATHOLOGY MARKET SNAPSHOT
  • FIG 69 MEA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2014-2024)
  • FIG 70 MEA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2014-2024)
  • FIG 71 MEA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 72 MEA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2014-2024)
  • FIG 73 MEA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2014-2024)
  • FIG 74 MEA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2014-2024)
  • FIG 75 MEA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2014-2024)
  • FIG 76 MEA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2014-2024)
  • FIG 77 MEA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2014-2024)
  • FIG 78 MEA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014-2024)
  • FIG 79 PRODUCT BENCHMARKING OF KEY PLAYERS
  • FIG 80 TECHNIQUE BENCHMARKING OF KEY PLAYERS
  • FIG 81 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 82 DANAHER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 83 F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2018)
  • FIG 84 QUEST DIAGNOSTICS INCORPORATED - REVENUE SPLIT BY SEGMENT (2018)
  • FIG 85 BIO-RAD LABORATORIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 86 AGILENT TECHNOLOGIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 87 NEOGENOMICS LABORATORIES INC. - REVENUE SPLIT BY SEGMENT (2018)
  • FIG 88 ABBOTT LABORATORIES - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 89 SONIC HEALTHCARE LIMITED - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)